World's Best Scientists 2026 revealed!
Paul S. Teirstein

Paul S. Teirstein

D-Index & Metrics

Medicine

D-Index
85
Citations
48331
World Ranking
14345
National Ranking
7252

Paul S. Teirstein publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paul S. Teirstein sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 332 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paul S. Teirstein D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paul S. Teirstein sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paul S. Teirstein is affiliated with Scripps Health in the United States and has contributed extensively to research primarily in the field of medicine, with a focus on cardiology and cardiovascular medicine.

The primary topics of their research include:

  • Cardiac Valve Diseases and Treatments
  • Coronary Interventions and Diagnostics
  • Infective Endocarditis Diagnosis and Management
  • Aortic Disease and Treatment Approaches
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research

They have published research spanning multiple subfields such as cardiology and cardiovascular medicine, surgery, epidemiology, pulmonary and respiratory medicine, and radiology, nuclear medicine, and imaging. Their frequent publication venues include:

  • Journal of the American College of Cardiology
  • European Heart Journal - Imaging Methods and Practice
  • Circulation Cardiovascular Interventions
  • bioRxiv (Cold Spring Harbor Laboratory)

Frequent coauthors in their research collaborations are:

  • Tanvir Bajwa
  • Didier Tchétché
  • Michael J. Reardon
  • John K. Forrest
  • G. Michael Deeb

Some of the recent papers featuring their work comprise:

  • 4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial (2023), Journal of the American College of Cardiology
  • 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis (2023), Journal of the American College of Cardiology
  • 2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients (2022), Journal of the American College of Cardiology
  • Artificial intelligence coronary computed tomography, coronary computed tomography angiography using fractional flow reserve, and physician visual interpretation in the per-vessel prediction of abnormal invasive adenosine fractional flow reserve (2024), European Heart Journal - Imaging Methods and Practice
  • Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients (2024), Circulation Cardiovascular Interventions

Best Publications

  • A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease

    David L Fischman;Martin B Leon;Donald S Baim;Richard A Schatz

  • Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

    Jeffrey W. Moses;Martin B. Leon;Jeffrey J. Popma;Peter J. Fitzgerald

  • Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients

    Jeffrey J Popma;G Michael Deeb;Steven J Yakubov;Mubashir Mumtaz

  • Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement

    Susheel K. Kodali;Mathew R. Williams;Craig R. Smith;Lars G. Svensson

  • Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

    Matthew J. Price;Peter B. Berger;Paul S. Teirstein;Jean-François Tanguay

  • Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention

    Matthew J. Price;Peter B. Berger;Paul S. Teirstein;Dominick J. Angiolillo

  • Catheter-based radiotherapy to inhibit restenosis after coronary stenting

    Paul S. Teirstein;Vincent Massullo;Shirish Jani;Jeffrey J. Popma

  • Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

    James J Ferguson;Robert M Califf;Elliott M Antman;Marc Cohen

  • Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation.

    Matthew J. Price;Sarah Endemann;Raghava R. Gollapudi;Rafael Valencia

  • Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting

    Martin B. Leon;Paul S. Teirstein;Jeffrey W. Moses;Prabhakar Tripuraneni

  • Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II.

    Gregg W. Stone;David E. Kandzari;Roxana Mehran;Antonio Colombo

  • Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study.

    R A Schatz;D S Baim;M Leon;S G Ellis

  • Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease

    Stephen G. Ellis;Dean J. Kereiakes;D. Christopher Metzger;Ronald P. Caputo

  • Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO System) to Prevent Stroke in High-Risk Patients With Non-Rheumatic Atrial Fibrillation : Results From the International Multi-Center Feasibility Trials

    Stefan H. Ostermayer;Mark Reisman;Paul H. Kramer;Ray V. Matthews

  • Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study

    Peter J. Fitzgerald;Akio Oshima;Motoya Hayase;Jonas A. Metz

  • Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial.

    Matthew J. Price;Dominick J. Angiolillo;Paul S. Teirstein;Elizabeth Lillie

  • Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention Results of the GOLD (AU-Assessing Ultegra) Multicenter Study

    Steven R. Steinhubl;J. David Talley;Gregory A. Braden;James E. Tcheng

  • Three-Year Clinical and Angiographic Follow-Up After Intracoronary Radiation Results of a Randomized Clinical Trial

    Paul S. Teirstein;Vincent Massullo;Shirish Jani;Jeffrey J. Popma

  • A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience

    Simon R. Dixon;José P.S. Henriques;Laura Mauri;Krischan Sjauw

  • Two-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement

    Susheel K. Kodali;Mathew R. Williams;Craig R. Smith;Lars G. Svensson

Frequent Co-Authors

Martin B. Leon
Martin B. Leon Columbia University Medical Center
Jeffrey W. Moses
Jeffrey W. Moses Columbia University Medical Center
Jeffrey J. Popma
Jeffrey J. Popma Beth Israel Deaconess Medical Center
Gregg W. Stone
Gregg W. Stone Icahn School of Medicine at Mount Sinai
Alexandra J. Lansky
Alexandra J. Lansky Yale University
Roxana Mehran
Roxana Mehran Icahn School of Medicine at Mount Sinai
Dean J. Kereiakes
Dean J. Kereiakes The Christ Hospital Health Network
George Dangas
George Dangas Icahn School of Medicine at Mount Sinai
David R. Holmes
David R. Holmes Mayo Clinic
Eric J. Topol
Eric J. Topol Scripps Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is just one of many rewarding fields in healthcare. For those interested in patient care but looking for alternate routes, consider nursing school that don't require teas exams. These programs can offer more flexible admissions and a quicker start to your career in nursing.

If you are interested in leadership roles, an online healthcare administration accelerated degree prepares students for management positions and can be completed in less time than traditional programs.

Registered nurses seeking career advancement can look into adn to fnp programs, which bridge entry-level nursing education to advanced practice roles, opening the door to higher salaries and greater responsibility.

For those interested in food science and wellness, pursuing a nutritionist online degree is a great option. These fully online programs can lead to careers in clinical nutrition, community health, and wellness coaching.

Best Scientists Citing Paul S. Teirstein

Trending Scientists

Recently Published Articles